Bradykinin
| Names | |
|---|---|
| IUPAC name
Bradykinin | |
| Systematic IUPAC name
(2S)-2-{(12S,32S,9S,12S,142S,17S)-11-[(2S)-2-Amino-5-(carbamimidoylamino)pentanoyl]-9-benzyl-12-(hydroxymethyl)-2,4,7,10,13,15-hexaoxo-5,8,11,16-tetraaza-1(2),3,14(1,2)-tripyrrolidina-19-benzenanonadecaphane-17-carboxamido}-5-(carbamimidoylamino)pentanoic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.000.362 |
| MeSH | Bradykinin |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C50H73N15O11 | |
| Molar mass | 1060.228 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
| kininogen 1 | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | KNG1 | ||||||
| Alt. symbols | KNG, BDK | ||||||
| NCBI gene | 3827 | ||||||
| HGNC | 6383 | ||||||
| OMIM | 612358 | ||||||
| RefSeq | NM_001102416 | ||||||
| UniProt | P01042 | ||||||
| Other data | |||||||
| Locus | Chr. 3 q21-qter | ||||||
| |||||||
| Bradykinin | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | Bradykinin | ||||||
| Pfam | PF06753 | ||||||
| InterPro | IPR009608 | ||||||
| |||||||
Bradykinin (BK) (from Greek brady- 'slow' + -kinin, kīn(eîn) 'to move') is a peptide that promotes inflammation. It causes arterioles to dilate (enlarge) via the release of prostacyclin, nitric oxide, and endothelium-derived hyperpolarizing factor, and induces smooth muscle constraction via prostaglandin F2. Bradykinin consists of nine amino acids, and is a physiologically and pharmacologically active peptide of the kinin group of proteins.
A class of drugs called angiotensin-converting-enzyme inhibitors (ACE inhibitors) increase bradykinin levels by inhibiting its degradation, thereby increasing its blood pressure-lowering effect. ACE inhibitors are used to treat hypertension and heart failure.
Category:
- Genes on human chromosome 3